
Glenmark initiates multi-nation Phase 3 clinical trial for lung cancer drug
The Hindu
Glenmark Pharmaceuticals initiates Phase 3 trial for Envafolimab, a novel drug for third-stage lung cancer in multiple countries.
More Related News

Glenmark Pharmaceuticals initiates Phase 3 trial for Envafolimab, a novel drug for third-stage lung cancer in multiple countries.